Adiponectin and its role in the patogenesis of obesity, diabetes mellitus and insulin resistance;Adiponektyna i jej rola w patogenezie otyłości, cukrzycy i insulinooporności

Polski Merkuriusz Lekarski

Volumn 20, Issue 117, 2006, Pages 355-357

  Owecki, Maciej ^a,b,c   Sowiński, Jerzy ^a,b  

^a Katedra i Klinika Endokrynologii   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Oddział Kliniczny Endokrynologii Przemiany Materii i Chorób Wewnȩtrznych ^*  (Poland)

Author keywords

Adiponectin; Diabetes; Insulin; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; INSULIN; LIVER PROTEIN; MUSCLE PROTEIN;

ADIPONECTIN GENE; ADIPOR1 GENE; ADIPOR2 GENE; ADIPOSE TISSUE; ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE MODEL; GENE; INSULIN RESISTANCE; METABOLIC BALANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, CELL SURFACE;

EID: 33645687441     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Arita Y., Kihara S., Ouchi N. i wsp.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
2. Berg A.H., Combs T.P., Du X. i wsp: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 2001, 7, 887-888.
3. Combs T.P., Berg A.H., Obici S. i wsp.: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Investig., 2001, 108, 1875-1881.
4. Daimon M., Oizumi T., Saitoh T. i wsp.: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care, 2003, 26, 2015-2020.
5. Duncan B.B., Schmidt M.I., Pankow J.S. i wsp.: Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes, 2004, 53, 2473-2478.
6. Hara K., Boutin P., Mori Y. i wsp: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes, 2002, 51, 536-540.
7. Kissebah A.H., Sonnenberg G.E., Myklebust J. i wsp.: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci., USA, 2000, 97, 14478-14483.
8. Kubota N., Terauchi Y., Yamauchi T. i wsp: Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277, 25863-25866.
9. Lindsay R.S., Funahashi T., Hanson R.L. i wsp.: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 2002, 360, 57-58.
10. Ouchi N., Kihara S., Arita Y. i wsp: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 103, 1057-1063.
11. Pittas A.G., Joseph N.A., Greenberg A.S: Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab., 2004, 89, 447-452.
12. Scherer P.E., Williams S., Fogliano M. i wsp.: A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-26749.
13. Snehalatna C., Mukesh B., Simon M. i wsp.: Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003, 26, 3226-3229.
14. Spranger J., Kroke A., Mohlig M. i wsp.: Adiponectin and protection against type 2 diabetes mellitus. Lancet, 2003, 361, 226-228.
15. Stumvoll M., Tschritter O., Fritsche A. i wsp.: Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes, 2002, 51, 37-41.
16. Tomas E., Tsao T.S., Saha A.K. i wsp.: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci., USA, 2002, 99, 16309-16313.
17. Vionnet N., Hani El H., Dupont S. i wsp.: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet., 2000, 67, 1470-1480.
18. Weyer C., Funahashi T., Tanaka S. i wsp.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 2001, 86, 1930-1935.
19. Yamauchi T., Kamon J., Ito Y. i wsp.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423, 762-769.
20. Yamauchi T., Kamon J., Minokoshi Y. i wsp.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med., 2002, 8, 1288-1295.
21. Yamauchi T., Kamon J., Waki H. i wsp.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 2001, 7, 941-946.
22. Yildiz B., Suchard M., Wong M.: Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad. Sci., USA, 2004, 28, 10434-10439.